Super-Resolution Ultrasound Localization Microscopy Based on a High
  Frame-rate Clinical Ultrasound Scanner: An In-human Feasibility Study by Huang, Chengwu et al.
Super-Resolution Ultrasound Localization Microscopy Based 
on a High Frame-rate Clinical Ultrasound Scanner: An In-
human Feasibility Study 
Chengwu Huang1,§, Wei Zhang2,§, Ping Gong1, U-Wai Lok1, Shanshan Tang1, Tinghui Yin2, Xirui 
Zhang3, Lei Zhu3, Maodong Sang3, Pengfei Song4, 5, Rongqin Zheng2,*, Shigao Chen1,* 
 
1 Department of Radiology, Mayo Clinic College of Medicine and Science, Mayo Clinic, 
Rochester, MN, USA 
2 Department of Ultrasound, Guangdong Key Laboratory of Liver Disease Research, Third 
Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China 
3 Shenzhen Mindray Bio-Medical Electronics Co. Ltd. Shenzhen, Guangdong, China 
4  Beckman Institute, University of Illinois at Urbana-Champaign, Urbana, IL, USA 
5 Department of Electrical and Computer Engineering, University of Illinois at Urbana-
Champaign, Urbana, IL, USA 
 
§ These authors contributed equally to this work. 
 
 
*Corresponding Authors: 
 
Dr. Shigao Chen     
 Department of Radiology    
 Mayo Clinic   
 200 First Street SW     
 Rochester, MN 55905      
 Email: Chen.Shigao@mayo.edu  
 Dr. Rongqin Zheng     
 Department of Ultrasound 
Guangdong Key Laboratory of Liver Disease Research  
 Third Affiliated Hospital of Sun Yat-Sen University    
 600 Tianhe Road, Guangzhou 510630, China 
 Email: zhengrq@mail.sysu.edu.cn 
 
Competing Interests: The authors declare no competing interests. 
Funding: The study was supported by the National Institute of Diabetes and Digestive and 
Kidney Diseases under R01DK120559, and by the National Cancer Institute under 
R00CA214523. The content is solely the responsibility of the authors and does not necessarily 
represent the official views of the National Institutes of Health. 
Abbreviations: 
ULM = ultrasound localization microscopy, MB = microbubble, CEUS = contrast-enhanced 
ultrasound, HFR = high frame-rate  
  
Abstract 
Background: 
Non-invasive detection of microvascular alterations in deep tissues in vivo provides critical 
information for clinical diagnosis and evaluation of a broad-spectrum of pathologies.  Recently, 
the emergence of super-resolution ultrasound localization microscopy (ULM) offers new 
possibilities for clinical imaging of microvasculature at capillary level. Currently, the clinical utility 
of ULM on clinical ultrasound scanners is hindered by the technical limitations, such as long 
data acquisition time, high microbubbles (MBs) concentration, and compromised tracking 
performance associated with low imaging frame-rate. Here we present a robust in-human ULM 
on a high frame-rate (HFR) clinical ultrasound scanner to achieve super-resolution microvessel 
imaging using a short acquisition time (< 10s). Ultrasound MB data were acquired from different 
human tissues, including a liver, a kidney, a pancreatic tumor, and a breast mass using an HFR 
clinical scanner. By leveraging the HFR and advanced processing techniques including sub-
pixel motion registration, MB signal separation, and Kalman filter-based tracking, MBs can be 
robustly localized and tracked for successful ULM under the circumstances of relatively high MB 
concentration associated with standard clinical MB administration and limited data acquisition 
time in humans. Subtle morphological and hemodynamic information in microvasculature were 
demonstrated based on data acquired with single breath-hold and free-hand scanning. 
Compared with contrast-enhanced power Doppler generated based on the same MB dataset, 
ULM showed a 5.7-fold resolution improvement in a vessel based on a linear transducer, and 
provided a wide-range blood flow speed measurement that is Doppler angle-independent. 
Microvasculatures with complex hemodynamics can be well-differentiated at super-resolution in 
both normal and pathological tissues. This study demonstrated the feasibility of ultrafast in-
human ULM in various human tissues based on a clinical scanner that supports HFR imaging, 
and showed a great potential for the implementation of super-resolution ultrasound microvessel 
imaging in a myriad of clinical applications involving microvascular abnormalities and 
pathologies.  
  
Introduction 
Microvasculature plays a critical role in blood supply for effective oxygen and nutrient delivery 
and metabolic demand of the tissue. Abnormal alterations of microvasculature are linked to a 
broad spectrum of diseases, such as arteriolosclerosis, diabetes, diabetes, chronic kidney 
diseases, hepatic fibrosis and cirrhosis, inflammatory bowel disease, and cancer (1-5). For 
example, diabetes is known to be related to various long-term microvascular complications, 
such as retinopathy and nephropathy, which lead to structural and functional vascular changes, 
eventually resulting in organ damage (2). The complications may have emerged in the level of 
small vessels long before they manifest as a symptom in the level of organs. Pathological 
angiogenesis, a hallmark of cancer, is another characteristic disease state that is associated 
with unbalanced development of microvasculature (e.g., chaotic, tortuous, and disordered small 
vessels that cause impaired blood flow) (1, 3). As such, early detection and characterization of 
the pathological changes of the microvasculature are of significant clinical value for disease 
prevention, intervention, and treatment. Despite the significance of microvasculature detection, 
there is no viable clinical tool that provides non-invasive and sufficient resolution for in vivo 
assessment of human tissue microvasculature (e.g., < 100 µm) at a clinically relevant depth 
(several centimeters to > 10 centimeters) (6, 7). Ex vivo histopathology remains the only clinical 
tool and gold standard for evaluating the state of health for tissue microvasculature. Current 
clinical modalities for vasculature imaging such as magnetic resonance imaging (MRI) and 
computed tomography (CT) can assess tissue perfusion or vascular structure with high 
sensitivity and deep penetration, but the spatial resolution is limited to the level of submillimeter 
or millimeter (> 100 µm) (8).  Doppler ultrasound is another widely available modality for blood 
flow imaging. However, conventional ultrasound Doppler is only sensitive to fast flow (for 
example, > 1 cm/s) in relatively large vessels, and is challenging for imaging microvessels (6). 
Contrast-enhanced ultrasound (CEUS), which is routinely used in clinical practice for tissue 
perfusion imaging, allows a much higher sensitivity to flow in small vessels (from capillaries to 
tens of micrometers) by leveraging the microbubbles (MBs) that pass through the capillaries as 
an ultrasound contrast agent (9). However, CEUS is still not capable of resolving microvessels 
because it is confined by the same resolution limit as conventional ultrasound, which is 
approximately equal to the wavelength of ultrasound (e.g., from 100 um at 15 MHz to 1000 um 
at 1.5 MHz). 
Recently, the invention of super-resolution ultrasound localization microscopy (ULM) achieved a 
substantial improvement of ultrasound spatial resolution in imaging microvasculature (6, 7, 10). 
Instead of using the diffraction-limited contrast microbubble (MB) signal for imaging as in 
contrast-enhanced ultrasound (CEUS), ULM uses the location of the spatially isolated MBs for 
imaging. ULM has demonstrated an approximately ten-fold improvement in spatial resolution 
while preserving the imaging penetration of conventional ultrasound (6, 7, 10). In addition, 
movement of individual MBs can be tracked to provide an accurate measurement of a wide 
range of blood flow speed that is Doppler angle-independent. Owing to the significant clinical 
potential, ULM has rapidly gained traction in the research field with focus on the technical 
development, optimization, and demonstration (11-30), which includes various phantom 
validation studies (17, 19, 31-35) and a wide range of preclinical in vivo studies in different 
tissues (e.g., brain, tumor, kidney, ear, skeletal muscle, lymph node) of various animal models 
including mouse (11, 12, 14), rat (10, 13, 15, 30, 36-38), rabbit (18, 22, 26), and chicken embryo  
(16, 39).  
As an emerging technology, most of the ULM implementations to date are still limited to 
research ultrasound scanners with high frame-rate (HFR) imaging capability. There are pilot in-
human studies in imaging breast tumors (11, 40), lower limb (41), and prostate cancer (42) 
using conventional clinical scanners that typically operated at low imaging frame-rates (around 
10 to 15 Hz). However, it is challenging to accurately localize and track fast moving MBs with a 
low frame-rates, which compromises the performance of the ULM. Although MB dilution is 
commonly used to mitigate the issue, it is not a standard clinical procedure for MB 
administration. Another challenge with conventional ULM is the long data acquisition time, which 
requires the same imaging plane to be continuously imaged for dozens of seconds and even 
several minutes (11, 40-42). In practice this is very challenging for free-hand scanning, 
especially for organs like kidney and liver where tissue motion from patient breathing is 
significant and difficult to manage. While patient breath-holds mitigate the issue of tissue 
motion, it is infeasible to suspend voluntary respiration over the entirety of ULM data acquisition.  
To address these limitations of ULM, we recently developed an MB signal separation method 
and a Kalman filter-based tracking algorithm to facilitate accurate localization and tracking of 
MBs without the need of MB dilution. Our methods also significantly shorten ULM data 
acquisition time to only several seconds (39, 43). In this paper, we take advantage of a clinical 
scanner with the capability of HFR imaging (e.g., > 500 Hz) and implement these algorithms to 
realize robust in-human ULM with a short acquisition time (< 10 s). We applied the MB signal 
separation method on the clinical HFR ultrasound system to enable accurate localization and 
tracking of MBs using standard clinical MB administrations without MB dilution(39). We further 
improved microvessel delineation by implementing the Kalman filter-based tracking algorithm on 
the clinical HFR system (43). We demonstrated successful in-human ULM using data acquired 
from a single breath-hold and free-hand scanning.  The utility of the technique was tested in 
various in vivo human tissues including liver, kidney, and pancreatic and breast tumors. The 
results demonstrated a 57.5 µm spatial resolution and an imaging penetration depth of up to 8 
cm using a linear array transducer (3.6 MHz). To the best of our knowledge, this is the first in-
human ULM imaging using a clinical scanner that supports HFR imaging. With the trend of more 
and more clinical ultrasound scanners supporting HFR imaging, our study demonstrated the 
feasibility of implementing ULM on these scanners and paved the way for future clinical 
translations of the ULM technology.  
  
Methods 
Study Protocol 
This study was approved by the Institutional Review Board (IRB) of the Third Affiliated Hospital 
of Sun Yat-Sen University and the IRB of Mayo Clinic. Written informed consent was obtained 
from each patient. For each patient, a bolus of MB solution (SonoVue, Bracco, Milan, Italy) was 
injected through intravenous injection, followed by a 5 ml saline flushing. The dosage of MB was 
organ-specific, similar to that in clinical CEUS (see details in Table I). Real-time CEUS was 
used to guide the image plane and monitor the MB signal right after the MB injection with free-
hand scanning. Then the sonography switched the scanner to an ultrafast plane-wave imaging 
mode and started the data acquisition. The beamformed in-phase/quadrature (IQ) data were 
saved for ULM post-processing in MATLAB (MathWorks Inc., Natick, MA) offline. During the 
data acquisition, the patients were asked to hold the breath for a data acquisition time < 10 
seconds. The data were acquired from different tissues, including a liver, a kidney, a pancreatic 
and a breast tumor from different patients.  
Ultrasound Imaging Settings 
An HFR clinical ultrasound scanner (Resona 7, Shenzhen Mindray Bio-Medical Electronics Co. 
Ltd., Shenzhen, China) and an L9-3U linear array transducer (6.0 MHz center frequency, 
bandwidth 9.8MHz – 1.8MHz) were used for both real-time CEUS and ULM data acquisition. 
Ultrafast imaging was performed using a 5-angle plane-wave compounding (-10° to 10°, 3.6 
MHz frequency, 1.5 cycles of pulse length) with a compounded frame-rate of several hundred 
Hertz (depending on the image depth, Table 1). A stack of several thousands of ultrasound 
frames (Table 1) were acquired for each tissue for the given acquisition time and frame-rate.  
Ultrasound signal processing 
A spatiotemporal singular-value-decomposition (SVD) based clutter filter was applied to the 
ultrasound data (Fig.1a) to extract moving MB signals (Fig. 1b, corresponding to the median-to-
high-rank components) (44, 45). The MB signals can be used to generate contrast-enhanced 
power Doppler images by accumulating the power of the MB signals along the temporal 
dimension. It should be noted that this power Doppler image is based on the contrast MB 
signals and thus different from the non-contrast conventional power Doppler image. The same 
MB data will be used for localization and tracking in ULM. In this study, a phase correlation-
based sub-pixel motion estimation method was applied to estimate tissue motion in 2-D based 
on the IQ data (with MB signals removed by the SVD filter) (43, 46), which will be utilized in the 
following steps to register the MB signals for robust tissue motion correction. By separating the 
MB signals and tissue signals, the influence of the moving MB signals on the tissue motion 
estimation can be suppressed (47). 
MB localization and tracking for ULM 
An MB signal separation method was applied to break down the original MB data into several 
subsets of low MB concentration data based on MB flowing speeds and directions (39). With 
MB separation, the spatially overlapping MBs that are otherwise discarded in the conventional 
ULM processing may now be utilized for robust localization and tracking separately in each 
subset, to improve the efficiency and accuracy of MB event detection for the limited acquisition 
time (39). For each subset, tissue motion was removed based on the above motion estimation. 
The motion-corrected MB signals were equalized by a noise profile and then spatially 
interpolated to an axial-lateral pixel resolution of 57.5 µm using a 2-D spline interpolation. An 
intensity thresholding was applied to remove the noisy background. A 2-D normalized cross-
correlation between interpolated MB data and a predefined point-spread function (PSF) was 
calculated, followed by a thresholding to remove pixels with correlation coefficient < 0.6. MB 
centroids were localized as the regional peaks of the cross-correlation map (Fig. 1b). A bipartite 
graph-based pairing algorithm was applied to track the movement of individual MBs over 
frames. Only those MBs consistently tracked over ten compounded ultrasound frames were 
preserved as confident MB events for generating microvessel images. Each MB trace was 
smoothed and the gaps in between MB positions on each MB trace were inpainted to further 
improve the microvessel delineation using a Kalman-filter-based algorithm (43). An MB 
movement direction and acceleration constraint were used to further remove noisy MB traces 
(43), before accumulation of the MB traces from all the subsets to generate the final microvessel 
images (39).  
Results 
Robust ULM with Ultrafast imaging  
The accumulation of MB positions from all the subsets generates an MB density image that 
depicts the vessel morphology (Fig. 1c, without motion registration). The Kalman filter-based 
algorithm was applied to smooth and inpaint the MB traces (43), further improving ULM image 
quality (Fig. 1e). Fig. 1d shows an example of a lateral motion curve (blue line). Even with 
breath-holding, tissue motion was still present (200 µm – 400 µm), which resulted in 
deteriorated microvessel imaging (Fig. 1e). Here a robust phase correlation-based motion 
correction method based on ultrafast ultrasound imaging was used to remove the tissue motion. 
The residual tissue motion was reduced to < 15 µm (red line, Fig. 1d), which falls well below the 
pixel size of the ULM image (57.5 µm × 57.5 µm). The motion-corrected microvessel image is 
depicted in Fig. 1f, showing an improved resolution.  
ULM of Healthy Human Liver Microvasculature   
The ULM images of a human liver with a field-of-view (FOV) of 58 mm × 44 mm (depth × width)  
derived from 6.0 s of data (415.3 Hz frame-rate) are shown in Fig. 2. Fig. 2b shows the zoomed-
in region depicting the detailed microvessel structures with a wide range of vessel diameters 
(millimeters to tens of micrometers). To further highlight the ULM resolution, a smaller region 
(indicated by the rectangle in Fig. 2b) was magnified (Fig. 2c), and compared with contrast-
enhanced power Doppler image generated using the same HFR dataset as those used for ULM 
(Fig. 2d, see Sub. Fig. 1a for a larger FOV image).  There are some discontinuities of the vessel 
profile inside the relative large vessel indicated by the arrow in Fig. 2c, which may be associated 
with the limited number of MB tracks detected in a short acquisition time.  Vessel profile along 
the dashed line in Fig. 2c indicates a vessel width of 153 µm (full-width at half maximum, 
FWHM), showing about a 5.7-fold improvement of spatial resolution compared with the contrast-
enhanced power Doppler image (869 µm, Fig. 2e) for the current imaging settings. Two 
branching vessels at the bifurcation with a width of 158 µm and 105 µm (575 µm distance), as 
indicated in Fig. 2e (right side), can be clearly resolved, but were inseparable in the power 
Doppler. Fig. 2f shows the bi-directional microvessel intensity image, similar to Fig. 2b but with 
red color indicates the upward flow and blue color represents the downward flow. Reasonable 
gradients of flow speeds from larger vessels to smaller vessels can be observed, as evidenced 
in the velocity magnitude image in Fig. 2g (see the bi-directional version of microvessel velocity 
image in Sub. Fig.1c). A wide range of flow speeds (from about 1 mm/s to about 60 mm/s) can 
be measured as indicated by the distribution of the velocity magnitude (Fig. 2h).  
ULM of Healthy Human Kidney  
The cortex of the human kidney represents a complex flow pattern with high perfusion, dense 
microvascular structure. A B-mode image of the kidney was shown in Sup. Fig.2a, indicating the 
orientation of the image plane. MB separation was able to separate MBs with opposite flow 
directions in cortical arteries and veins, thus yielding a higher number of high-fidelity MB traces 
for successful ULM with a short acquisition time (9.7 s of data with 250.4 Hz frame-rate), as 
shown in Fig. 3. The super-resolution microvessel intensity, bi-directional intensity and velocity 
magnitude images are shown in Fig. 3a-3c, respectively. Well-defined microvessel structure can 
be resolved, showing clear vessel boundaries in the cortex region, which are difficult to discern 
in the power Doppler image (Sup. Fig. 2b). Fig. 3d and 3e show the magnified region of the bi-
directional intensity and velocity magnitude images at the upper cortex of the kidney, showing 
the details of the dense microvasculature and complex hemodynamics. In the bi-directional 
intensity image (Fig. 3d), a pixel is either assigned to red or blue colors even though there may 
be several vessels with opposite flow directions passing thought the same pixel, which can lead 
to the ‘aliasing-like’ artifact indicated by the arrows in Fig. 3d. This can also easily appear in the 
horizontal vessel where flow direction is close to zero (or 180°) and pixels are hard split into red 
and blue colors based on the sign of the flow direction. Flow directions and the neighboring 
arteries and veins with opposite flows can be well-differentiated (Fig. 3d, and Sup. Fig. 2c-2d).  
ULM of In-human Pancreatic Tumor and Breast Tumor 
We tested the ULM in a human pancreatic tumor with a depth down to 60 mm, and a shallow 
breast tumor down to 15 mm (Figs. 4-5). The pancreatic tumor data was acquired from a 70-
year-old patient with an acquisition time of 5.2 s (frame-rate 415.3 Hz). This tumor had a large 
size with a dimension of about 164 mm × 65 mm × 66 mm with an anterior lesion boundary at a 
depth of around 10 mm, as assessed from the clinical ultrasound and CT scan. The acquired 
ultrasound data can only cover a portion of the lesion, as indicated in Fig. 4. The B-mode 
ultrasound indicates a mixed cystic solid mass with a dimension of 50 mm × 50 mm in the 
image FOV (with the boundary of the tumor was indicated by white arrows in Fig. 4a). ULM 
showed both the morphological and hemodynamic characteristics with a high spatial resolution 
(Fig. 4b- 4d). Figs. 4e-4f shows the magnified region of the power Doppler, ULM intensity, and 
velocity magnitude images at a deeper region (40 to 55 mm), respectively, revealing 
substantially improved resolution by the ULM. Feeding and draining vessels with opposite flow 
directions can be well-differentiated in the bi-directional intensity image (Fig. 4c, indicated by 
white and yellow arrows, respectively) or in the flow direction image and bi-directional velocity 
image (Sup. Fig. 3b and 3c).  
The B-mode ultrasound of the breast tumor is shown in Fig. 5a, with white arrows indicating the 
boundary of the lesion. The data was acquired from a ductal carcinoma in situ (DCIS) 
diagnosed with histopathology on a 49-year-old patient who had been treated with neoadjuvant 
chemotherapies (9.0 seconds of data, frame-rate at 622 Hz). Similarly, substantial improvement 
in resolution was observed for ULM (Figs. 5b-5d) over the power Doppler (Sup. Fig. 4a). Local 
regions of power Doppler, ULM density and velocity magnitude images are shown in Figs. 5e-
5g, respectively, for detailed visualization.  
  
Discussion 
Conventional ULM requires a long data acquisition time (dozens of seconds to minutes) to 
accumulate a sufficient amount of isolated MB signals for full delineation of the 
microvasculature. With the combination of HFR ultrasound imaging and advanced post-
processing techniques (MB separation, Kalman-filter tracking, and sub-pixel motion registration) 
presented in this paper,  robust ULM can be accomplished in vivo in humans using standard 
clinical procedure of MB administration and short data acquisition with a single breath-hold (< 
10s), and free-hand scanning.  In this study, we demonstrated the feasibility of implementing 
fast and robust ULM on a clinical ultrasound scanner that is capable of HFR imaging. We 
successfully performed ULM imaging in various human tissues in vivo. The results showed well-
defined morphological and functional features in the microvasculature in both healthy (liver, 
kidney) and pathological tissues (pancreatic and breast tumors). Given that more and more 
clinical ultrasound scanners support the HFR imaging, there is a great potential for the methods 
presented in this paper to be widely distributed to enhance the clinical accessibility of ULM.  
Contrast-enhanced power Doppler image derived from the same dataset used for ULM 
processing was utilized as a benchmark for resolution comparison in this study. In liver vessels 
with clear vascular branches at a depth of around 35 mm, we showed an about 5.7-fold 
resolution improvement of ULM compared with the contrast-enhanced power Doppler image. It 
should be noted that this improvement evaluation was based on one single vessel (Fig. 2c-2e), 
which has a vessel width of 153 µm (FWHM) measured in ULM and 869 µm measured in power 
Doppler image, and does not represent the highest resolution that can be achieved by either 
ULM or power Doppler image. In fact, contrast-enhanced power Doppler image, similar to the 
conventional ultrasound, can potentially achieve an axial resolution of approximately half-
wavelength to one-wavelength, which is about 214 µm to 428 µm for the 3.6 MHz center 
frequency. This spatial resolution by conventional ultrasound image can be increased by using a 
higher ultrasound frequency, but still limited ultrasound diffraction. Furthermore, a lateral profile 
was used to measure the vessel width here (Fig. 2e, 869 µm), which was related to the lateral 
resolution of the ultrasound image and was expected to be much worse than the ultrasound 
resolution in the axial direction. Nevertheless, by using the same data set under the same 
imaging settings, the ULM is shown to be capable of imaging vasculature with several-fold 
resolution improvement in vivo.   
In this study, the super-resolved microvessel images were reconstructed at a 57.5 µm 
axial/lateral pixel resolution. This spatial resolution can be further improved by using a smaller 
pixel size down to about 1/20 to 1/10 of the acoustic wavelength (that is, 21 µm to 43 µm for a 
3.6 MHz imaging frequency). However, a much longer acquisition time will be required to fully 
populate the microvasculature at such fine resolutions (6, 48-50). The required acquisition time 
for imaging capillary flows has been thoroughly evaluated by Christensen-Jeffries et al (49), 
Hingot et al (48), and Lowerison et al (50). that an extremely long time (e.g., tens of minutes) 
would be necessary for the capillary networks to be fully filled by MBs. Therefore, it is a 
physiological limitation of the technique that it would not be possible to image the capillary 
networks at the level of micrometers in less than 10 s used in this study.  While increasing the 
MB concentration can speed up capillary perfusion of MBs, it also increases the challenge  to 
obtain isolated MB signals for ULM imaging with elevated MB concentration even with the MB 
separation technique. Therefore, this is a tradeoff between the resolution of microvessel 
imaging and clinically practical condition of data acquisition time. As such, the inability to resolve 
full capillary bed remains a limitation for in-human ULM. Furthermore, the accuracy of motion 
registration will also limit the capability of imaging capillaries in human in vivo even a long 
acquisition is applied, especially for the liver or kidney, where tissue motion is significant and 
inevitable. However, for clinical applications such as liver and kidney the velocities in the images 
are mainly in the range of tens of millimeters per second, which are flows 10-20 times faster 
than that in the capillary networks. This level of vessels is supposed to be filled by MB much 
faster (may be tens of times faster) than capillaries with the slower flow. Based on our results in 
this study, it ‘s possible to image vessels smaller than 100 µm using several seconds of data 
acquisition and using clinical relevant MB concentrations.  Except for the practical condition for 
clinical scanning, the clinical needs for the imaging resolution of in-human ULM may also need 
to be considered. Whether the capability of resolving vessels at the level of arterioles and 
venules is adequate for clinical assessment of microvascular pathologies remains to be 
investigated. 
Except for morphology imaging of the microvasculature, another advantage of ULM is the 
capability of providing 2-D flow velocity estimation that is Doppler angle-independent by tacking 
the individual MB movement. However, it typically requires much longer acquisition time (e.g., 4 
times longer) to reconstruct well-developed velocity profiles inside the vessels than the time 
required for reconstructing a microvessel intensity image (48). For each MB track, 
instantaneous MB moving velocity can be accurately measured, and the final velocity image is 
generated by averaging all velocity estimates of individual MBs passing through the same pixel. 
The instantaneous moving speed of different detected MBs pass through the same vessel or 
pixel can be very different due to the hemodynamic change associated with the cardiac phase, 
and the poor elevation resolution. It may only need at least one MB to reconstruct a pixel of a 
vessel for the morphology image. However, to accurately estimate the velocity profiles, multiple 
MBs passing through the same pixel will be necessary for a stable averaged velocity estimate. 
Therefore, even morphology image can be very well-reconstructed, the number of MBs detected 
may not be sufficient to provide smooth velocity estimation in some of the microvessels, which 
is an inherent limitation of the ULM based on short acquisition times. As a consequence, there 
are some discontinuities and variations of velocity profiles observed in the velocity images in 
this study. There are possibilities that different velocities appear in one single vessel or a 
relatively larger vessel shows a slower flow than the tiny branches. This issue of undersampling 
of velocity profiles would be potentially improved with more MB detections using a longer 
acquisition time. Nevertheless, the flow direction is less related to the cardiac phase and can be 
accurately estimated even there are only a few MBs passing through one pixel, which will 
provide added information combined with the morphology image, such as the bi-directional 
intensity image depicting both flow direction information and morphological information of the 
microvasculature.  
A relatively large FOV and clinical relevant penetration depths were demonstrated for ULM in 
this study. However, since a linear array transducer was used, the optimal imaging performance 
was found mainly in depth less than about 5 cm. For some applications such as imaging deeper 
abdominal tissues (> 5 cm), a curved array or phased array transducer operating at lower 
frequencies can be deployed. As a pilot study, only a linear array transducer was used here to 
demonstrate in-human ULM, and the same ultrasound frequency (3.6 MHz) was used here for 
all of the organs from the shallowing breast tissue to the deeper kidney tissue for the purpose of 
concept proofing. However, the methods presented in this study can be conveniently translated 
to other transducers at different frequencies optimized for different applications. One limitation 
of the study is that there was no ground truth for validating the microvasculature imaged by 
ULM. This is a common challenge for in vivo studies. Nevertheless, we were able to obtain 
physiologically reasonable microvascular images with well-defined vessel network. The ULM 
requires a certain period of acquisition time (< 10 s in this study) to collect data of a sufficient 
number of MBs filling in the vasculature, which prohibits it from being a real-time imaging 
modality. Moreover, post-processing of a large amount of ULM data associated with long 
acquisition time, including SVD clutter filtering, MB localization, pairing, and tracking, is still 
time-consuming, which, however, has the possibility to be speeded up via parallel processing 
using high power GPU.  In addition, two-dimensional (2-D) ULM suffers from inaccurate blood 
flow velocity estimation even with very long acquisition time due to the tracking of 3-D MB 
movements using a 2-D imaging plane. The 2-D ultrasound image casts a slice thickness in the 
elevational direction (perpendicular to the 2-D image plane), which renders traces of MBs that 
are moving in-and-out-of-plane. 3-D ULM is necessary to accurately measure blood flow speed 
in all three dimensions. Additionally, 3-D imaging can also enhance the performance of motion 
correction by providing 3-D motion estimation.  
In conclusion, we demonstrated successful in-human ultrasound localization microscopy (ULM) 
imaging using an HFR clinical ultrasound scanner, and showed high-definition morphological 
and functional imaging of microvasculature at super-resolution.  By leveraging the high imaging 
speed and advanced post-processing algorithms, in-human ULM can be accomplished using 
data acquired from a single breath-hold (< 10 s) and free-hand scanning. Successful ULM 
imaging was demonstrated in various in vivo human tissues including liver, kidney, and 
pancreatic and breast tumors, showing the in-human feasibility of the technique. The results of 
the study show great potential for future clinical translations of ULM based on clinical HFR 
scanners that are rapidly becoming available around the world.  
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Tables 
TABLE I 
ULTRASOUND IMAGING SETTINGS FOR SPECIFIC TISSUES IN THIS STUDY 
 Frame-rate (Hz) 
Data 
acquisition 
time (s) 
Number of 
ultrasound 
frames 
Bolus 
injection 
(ml) 
Liver 415 6.0  2487 2.4 
Kidney 250 9.7 2424 2.0 
Pancreatic tumor 415 5.2 2144 2.0 
Breast tumor 622 9.0 5575 3.0 
  
Figure Legends 
Figure 1. (a) Stack of B-mode images indicating original spatiotemporal ultrasound data from a 
healthy human liver (t represents slow time). (b) B-mode images of the MB signal extract from 
(a) with tissue clutter filtering. Centroids of MBs were localized and indicated by the red 
asterisks obtained from the cross-correlation with a predefined point-spread-function (PSF) of 
the system. (c) Accumulation of the MB centroid positions over time to generate an MB density 
map. (d) The estimated lateral tissue motion curve with respect to the first ultrasound frame 
before and after motion registration. (e) the microvessel density map obtained from 
accumulating MB positions with MB pairing, tracking, Kalman filtering, but without motion 
correction. (f) The microvessel density map with motion correction. Here, the example images in 
(c)(e)(f) were generated with 829 frames of MB data, corresponding to a data acquisition time of 
2.0 s. 
 
Figure 2. (a) Full FOV super-resolution ULM microvessel image of the healthy human liver 
overlaid on the B-mode image. (b) The zoomed-in local region as indicated by the white 
rectangle in (a).. (c) The magnified region indicated by the white rectangle in (b) highlighting a 
small branch of vessels. (d) The contrast-enhanced power Doppler image of the same branch of 
vessels in (c), which is obtained by accumulating the power of the MB signal over time. (e) Plots 
of a vessel profile along the white dashed line indicated in (c) using ULM (red curve)and power 
Doppler (blue curve). (f) Bi-directional super-resolution microvessel intensity image, similar to 
Fig. 2b but with red color indicates the upward flow and blue color represents the downward 
flow. (g) Super-resolution ULM microvessel velocity image of the healthy human liver, with 
colorbar indicating the magnitude of the velocity. The direction of the blood flow can be found in 
Sup. Fig. 1.  (h) The histogram of the blood flow speed distribution. 
 
Figure 3. (a) Super-resolution microvessel intensity image of a human kidney overlap on the 
ultrasound B-mode image. (b) corresponding bi-directional microvessel intensity image, similar 
to Fig. 3a, but with red color indicates the upward flow and blue color represents the downward 
flow. Neighboring cortical arteries and veins with opposite flow directions can be well-
differentiated at high spatial resolution. (c) Corresponding super-resolution microvessel velocity 
image of the human kidney, with colormap indicating the magnitude of the velocity. The 
direction of the blood flow can be found in Sup. Fig. 2(b). (d) Zoom-in region of the bi-directional 
super-resolution microvessel intensity image and (c) Zoom-in region of super-resolution 
microvessel velocity image indicated by the white rectangle in (c) showing dense 
microvasculature and complex hemodynamics in the renal cortex. 
 
Figure 4. (a) B-mode image of a pancreatic tumor from a 70-year-old patient, with white arrows 
roughly indicating the boundary of the lesion. (b) Super-resolution microvessel intensity image 
of the human pancreatic tumor.  (c) Corresponding bi-directional microvessel intensity image, 
similar to Fig. 4b but with red color indicates the upward flow and blue color represents the 
downward flow. (d) Corresponding super-resolution microvessel velocity image, with colormap 
indicating the magnitude of the velocity. The direction of the blood flow can be found in Sup. Fig. 
3b. (e)  Zoom-in region (indicated by the white rectangle in Fig. 4b) of the contrast-enhanced 
power Doppler image. (f) Corresponding zoom-in region of the super-resolution microvessel 
intensity image. (g) Corresponding zoom-in region of the super-resolution microvessel velocity 
image. 
 
Figure 5. (a) B-mode image of a breast tumor diagnosed as ductal carcinoma in situ from a 49-
year-old patient after neoadjuvant chemotherapies, with white arrows roughly indicating the 
boundary of the lesion. (b) Corresponding super-resolution microvessel intensity image of the 
human breast tumor.  (c) Corresponding bi-directional microvessel intensity image, similar to 
Fig. 5b but with red color indicates the upward flow and blue color represents the downward 
flow. (d) Corresponding super-resolution microvessel velocity image, with colormap indicating 
the magnitude of the velocity. (e)  Zoom-in region (indicated by the white rectangle in Fig. 4b) of 
the contrast-enhanced power Doppler image. (f) Corresponding zoom-in region of the super-
resolution microvessel intensity image. (g) Corresponding zoom-in region of the super-
resolution microvessel velocity image. 
 
Supplemental Figure 1. (a) Contrast-enhanced power Doppler image of the healthy human 
liver derived from the same MB data used for ULM. (b) Super-resolution microvessel image with 
the color map indicating the flow direction, where 0° indicates the left-to-right flow, 90° indicates 
the upward flow, and -90° representing the downward flow motion. (c) Bi-directional super-
resolution microvessel velocity image, with red color (positive) indicates the upward flow and 
blue color (negative) represents the downward flow.  
 
Supplemental Figure 2. (a) B-mode image of the human kidney. (b) Contrast-enhanced power 
Doppler image of the human kidney derived from the same MB data used for ULM.  (c) Super-
resolution flow direction image of the human kidney with the color map indicating the flow 
direction, where 0° indicates the left-to-right flow, 90° indicates the upward flow, and -90° 
representing the downward flow motion. (d) Bi-directional super-resolution microvessel velocity 
image, with red color (positive) indicates the upward flow and blue color (negative) represents 
the downward flow. 
Supplemental Figure 3. (a) Contrast-enhanced power Doppler image of the human pancreatic 
tumor derived from the same MB data used for ULM. (b) Super-resolution microvessel image of 
the human pancreatic tumor with the color map indicating the flow direction, where 0° indicates 
the rightward flow, 90° indicates the upward flow, and -90° representing the downward flow 
motion. (c) Bi-directional super-resolution microvessel velocity image, with red color (positive) 
indicates the upward flow and blue color (negative) represents the downward flow.  
 
Supplemental Figure 4. (a) Contrast-enhanced power Doppler image of the human breast 
tumor derived from the same MB data used for ULM. (b) Super-resolution microvessel image of 
the human breast tumor with the color map indicating the flow direction, where 0° indicates the 
rightward flow, 90° indicates the upward flow, and -90° representing the downward flow motion. 
(c) Bi-directional super-resolution microvessel velocity image, with red color (positive) indicates 
the upward flow and blue color (negative) represents the downward flow. 
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